These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9375836)

  • 1. Effect of desmopressin on protein S and antithrombin III in uremia.
    Akpolat T; Eser M; Albayrak D; Arik N
    Nephron; 1997; 77(3):362. PubMed ID: 9375836
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.
    Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S
    Nephron; 1993; 64(2):232-4. PubMed ID: 8321356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of desmopressin and dextran on coagulation and fibrinolysis in healthy volunteers.
    Flordal PA; Svensson J; Ljungström KG
    Thromb Res; 1991 Jun; 62(5):355-64. PubMed ID: 1716790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
    Nalçaci M; Pekçelen Y
    J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hemodialysis and long-term erythropoietin treatment on protein C, and on free and total protein S.
    Clyne N; Egberg N; Lins LE
    Thromb Res; 1995 Oct; 80(2):161-8. PubMed ID: 8588193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of protein C, protein S, and antithrombin III in newborns with sepsis.
    El Beshlawy A; Alaraby I; Abou Hussein H; Abou-Elew HH; Mohamed Abdel Kader MS
    Pediatr Crit Care Med; 2010 Jan; 11(1):52-9. PubMed ID: 19924026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
    Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
    Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
    [No Abstract]   [Full Text] [Related]  

  • 8. 1-Deamino-8-D-arginine vasopressin lowers protein C activity in uremics.
    Aunsholt NA; Schmidt EB; Stoffersen E
    Nephron; 1989; 53(1):6-8. PubMed ID: 2506477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement.
    Flordal PA; Ljungström KG; Svensson J; Ekman B; Neander G
    Thromb Haemost; 1991 Dec; 66(6):652-6. PubMed ID: 1796409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein C, protein S, and antithrombin III in twice-frozen plasma.
    Sivakumaran M; Long S; Drury M
    Transfusion; 2005 Feb; 45(2):281. PubMed ID: 15660840
    [No Abstract]   [Full Text] [Related]  

  • 11. Desmopressin induces decrease in platelet serotonin content in uremia.
    Małyszko J; Pietraszek MH; Azzadin A; Buczko W; Myśliwiec M
    Thromb Haemost; 1989 Jun; 61(3):537. PubMed ID: 2799766
    [No Abstract]   [Full Text] [Related]  

  • 12. A partial role of serotonin in normalization of the bleeding time by DDAVP in uraemic rats.
    Pietraszek M; Azzadin A; Buczko W; Malyszko J; Mysliwiec M
    Thromb Haemost; 1992 Nov; 68(5):625. PubMed ID: 1455414
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of main trials of recombinant human activated protein C in sepsis-are we encouraging more bleeding in neonates?
    Hsin Shieh H; Roseli Barreira E; Freitas Góes P; Bousso A; Ventura Brazilian GA; Melo AM; Ibidi SM
    Pediatr Crit Care Med; 2010 Nov; 11(6):767-8; author reply 768-9. PubMed ID: 21057275
    [No Abstract]   [Full Text] [Related]  

  • 14. Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation.
    Tabbara IA; Ghazal CD; Ghazal HH
    J Hematother; 1996 Feb; 5(1):79-84. PubMed ID: 8646485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
    Wygledowska G; Grygalewicz J; Matuszewska E
    Med Wieku Rozwoj; 2001; 5(4):377-88. PubMed ID: 12004145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III, protein C and protein S in children with chronic viral hepatitis B or C].
    Adamska I; Szaflarska-Szczepanik A; Chrobot A; Kulwas A; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2003; 7(2):289-97. PubMed ID: 12878800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between anti-coagulation system changes of coronary heart disease patients and different syndrome-type in TCM].
    Liang TJ; Gao SZ; Zhang FL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):599-600. PubMed ID: 8704425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAVP in uremia.
    Vicente V; Alberca I; Macias JF; Lopez Borrasca A
    Nephron; 1984; 36(2):145-6. PubMed ID: 6420716
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients.
    Pectasides D; Tsavdaridis D; Aggouridaki C; Tsavdaridou V; Visvikis A; Tsatalas K; Fountzilas G
    Anticancer Res; 1999; 19(4C):3521-6. PubMed ID: 10629646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.